Trilipix and Vitamin d drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Trilipix (choline fenofibrate) and Vitamin d (ergocalciferol). Common drug interactions include weight increased among females and renal failure among males.
The phase IV clinical study analyzes what interactions people have when they take Trilipix and Vitamin d. It is created by eHealthMe based on reports of 313 people who take the same drugs from the FDA, and is updated regularly.
What is Trilipix?
Trilipix has active ingredients of choline fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 5,915 Trilipix users. Check the latest studies of Trilipix.
What is Vitamin d?
Vitamin d has active ingredients of ergocalciferol. It is often used in low vitamin d. eHealthMe is studying from 294,095 Vitamin d users. Check the latest studies of Vitamin d.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
313 people who take Trilipix and Vitamin d together, and have interactions are studied.
What are the common drug interactions of Trilipix and Vitamin d, by gender? *
What are the common drug interactions of Trilipix and Vitamin d, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Trilipix and Vitamin d?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Trilipix and Vitamin d:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Trilipix:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Vitamin d:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Trilipix and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vitamin d and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
How the study uses the data?
The study uses data from the FDA. It is based on choline fenofibrate and ergocalciferol (the active ingredients of Trilipix and Vitamin d, respectively), and Trilipix and Vitamin d (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Gastroesophageal Reflux Disease and drugs of ingredients of rizatriptan benzoate - a second ago
- Drug interactions of Albuterol Sulfate and Cetirizine Hydrochloride - a second ago
- Could Fluoxetine cause Acute Kidney Failure? - 2 seconds ago
- Irinotecan Hydrochloride and Simvastatin drug interactions for men aged 60+ - 3 seconds ago
- Could Midazolam cause International Normalised Ratio Increased? - 9 seconds ago
- Could Fluoxetine cause Disinhibition? - 14 seconds ago
- Cefuroxime vs. Flagyl, side effect and effectiveness comparison - 14 seconds ago
- Drug interactions of Trilipix and Vitamin D - 17 seconds ago
- Abdominal Wall Haematoma and drugs of ingredients of heparin sodium - 18 seconds ago
- Atrial Fibrillation/Flutter and drugs of ingredients of tamsulosin - 19 seconds ago